Dr. Duna A. Raoof, MD

Dr. Raoof practices at Pacific Hills Surgery Center in Laguna Hills, California.

Dr. Raoof's NPI, 1437389822, was assigned on July 20, 2009. Dr. Raoof graduated from University Of Michigan Medical School in 2009. Dr. Raoof holds California license A136157.

Dr. Raoof's primary practice is Pacific Hills Surgery Center, at 24022 Calle De La Plata, #180, Laguna Hills, CA 92653. The practice phone is (714) 458-3551.

Dr. Raoof's primary practice is Pacific Hills Surgery Center in Laguna Hills, California. Dmand AI also links Dr. Raoof to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Raoof practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Raoof's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Raoof is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Raoof's licenses on file in 3 states: California, Massachusetts and Michigan.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, conjunctivitis, dry eye, eye infection or inflammation, eyelid inflammation and glaucoma among the conditions Dr. Raoof treats.

CMS data shows 2,864 Medicare services from Dr. Raoof across 16 procedure codes in 2024, for 756 Medicare patients. Medicare paid $328,523 for them.

CMS counts 756 Medicare patients who saw Dr. Raoof in 2024. The largest group is 65 to 74, with 344 patients. 75% of them have high cholesterol, and 65% have high blood pressure. 5% are also on Medicaid. Their average risk score is 1.00, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Raoof's median patient age at 69, with 57% women.

In 2024, Dr. Raoof wrote 1,266 Medicare Part D claims for 347 patients. 53% of them were for generic drugs. CMS names the drug for 1,155 of them, across 20 drugs with 11 or more claims each, at $156,945 in total drug cost. In 2023, CMS named 1,116 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Raoof for performance year 2024, reported as part of a group. Dr. Raoof accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 436 procedures of cataract surgery by Dr. Raoof, more than 94% of the clinicians it reports for that procedure.

Dmand AI links 8 papers to Dr. Raoof, published from 2017 to 2023. The most frequent topics are Adenocarcinoma, Dry Eye Syndromes and Esophageal Neoplasms. Dr. Raoof has published most often in Neoplasia. Dr. Raoof's most frequent co-authors are Jules Lin, MD, John Palmer Berdahl, MD and Preeya Kshettry Gupta, MD.

CMS Open Payments shows 471 general payments to Dr. Raoof from 32 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 65% of the total. Alcon Laboratories Inc paid the most, $40,843.

Dr. Raoof graduated from University Of Michigan Medical School in 2009.

Dr. Raoof is in network with 14 carriers, including Elevance, United Healthcare and Aetna. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.